Supplement |
Collections
Filters
-
Collection Type
-
-
Supplement |
Diabetic Retinopathy and Macular Oedema – UK Pathways and Management
This document provides a review on DR pathophysiology, clinical features, including grading/classification of DMO.
Image: Image © DavidKevitch/E+/Getty -
Supplement |
Action on neovascular age-related macular degeneration (nAMD): 2018 update
An expert clinical advisory group named Action on nAMD met on 16 March 2018 in Birmingham, UK, to explore and discuss multidisciplinary practice initiatives and service developments in the management of nAMD.
Image: Image © DavidKevitch/E+/Getty -
-
Supplement |
Proceedings from 'Clinical Audit in Retina 2016'
This supplement, and the meeting on which it is based (Park Plaza, Vauxhall Road, London, 20th April 2016), were sponsored by Novartis.
-
Supplement |
Action on Diabetic Macular Oedema (DMO)
This publication and the expert advisory group meeting (2 September 2016, London, UK), on which the supplement is based, were sponsored by Bayer to explore and discuss multidisciplinary practice initiatives and developments in the management of diabetic eye disease.
-
Supplement |
Aflibercept in Wet AMD Beyond the First Year of Treatment: Recommendations by an Expert Roundtable Panel
This supplement includes recommendations by an expert roundtable panel, London, UK, 5 November 2014.
-
Supplement |
Redesigning Services for the Management of Vitreomacular Traction and Macular Hole
The VMT Service Re-Design Advisory Board Meeting was heal in Birmingham, UK, 20 September 2013.
-
Supplement |
Idiopathic Vitreomacular Traction and Macular Hole: A Comprehensive Review of Pathophysiology, Diagnosis, and Treatment
This supplement has been funded by Alcon Eyecare UK, with medical writing provided on their behalf by 90TEN Healthcare.
-
Supplement |
Management of Retinal Vascular Diseases: A Patient-Centric Approach
This supplement was supported by Novartis Pharmaceuticals Limited (UK).
-
Supplement |
Action on AMD – Optimising Patient Management: Act Now to Ensure Current and Continual Delivery of Best Possible Patient Care
This document has been produced following an Action on AMD expert on capacity working group consensus meeting held in London in May 2010.
-
Supplement |
Focusing on Glaucoma Progression and the Clinical Importance of Progression Rate Measurement
Medical writing assistance was provided by Patricia Buchholz, Karlsruhe, Germany.